STUDY: COG ANBL1531 - JUBILANT DRAXIMAGE Inc. Protocol ANBL1531: A Phase III Study of 131I Metaiodobenzylguanidine (131I-MIBG) or Crizotinib Added to Intensive Therapy for Children With Newly Diagnosed High-Risk Neuroblastoma (NBL)

Project: Research project

Project Details

StatusActive
Effective start/end date6/5/208/31/50

Funding

  • Children's Hospital of Philadelphia
  • Children's Oncology Group